Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

15,235 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term clinical outcomes of patients diagnosed with pT1a-muscularis mucosae with lymphovascular invasion or pT1b after endoscopic resection for cT1N0M0 esophageal squamous cell carcinoma.
Kadota T, Sato D, Inaba A, Nishihara K, Takashima K, Nakajo K, Yukami H, Mishima S, Sawada K, Kotani D, Fujiwara H, Nakamura M, Hojo H, Yoda Y, Kojima T, Fujita T, Yano T. Kadota T, et al. Among authors: nakamura m. Esophagus. 2022 Jan;19(1):153-162. doi: 10.1007/s10388-021-00873-7. Epub 2021 Aug 22. Esophagus. 2022. PMID: 34420139
Frequency and predictors of detecting early locoregional recurrence/disease progression of oral squamous cell carcinoma with high-risk factors on imaging tests before postoperative adjuvant radiotherapy.
Kibe Y, Nakamura N, Kuno H, Hiyama T, Hayashi R, Zenda S, Motegi A, Hojo H, Nakamura M, Ariji T, Oyoshi H, Akimoto T. Kibe Y, et al. Among authors: nakamura m, nakamura n. Int J Clin Oncol. 2019 Oct;24(10):1182-1189. doi: 10.1007/s10147-019-01479-x. Epub 2019 Jul 9. Int J Clin Oncol. 2019. PMID: 31289957
Prospective evaluation of XRCC-1 Arg194Trp polymorphism as bio-predictor for clinical outcome in locally advanced laryngeal cancer undergoing cisplatin-based chemoradiation.
Raturi V, Hojo H, Bhatt MLB, Suhel M, Wu CT, Bei Y, Nakamura M, Okumura M, Zhang H, Parmar D, Badajena A, Singh R, Kumar S, Katiyar T, Gaur J. Raturi V, et al. Among authors: nakamura m. Head Neck. 2020 May;42(5):1045-1056. doi: 10.1002/hed.26083. Epub 2020 Jan 30. Head Neck. 2020. PMID: 31997432
Efficacy and safety of accelerated fractionated radiotherapy without elective nodal irradiation for T3N0 glottic cancer without vocal cord fixation.
Okumura M, Motegi A, Zenda S, Nakamura N, Hojo H, Nakamura M, Hirano Y, Kageyama SI, Arahira S, Parshuram RV, Kuno H, Hayashi R, Tahara M, Itoh Y, Naganawa S, Akimoto T. Okumura M, et al. Among authors: nakamura m, nakamura n. Head Neck. 2020 Aug;42(8):1775-1782. doi: 10.1002/hed.26092. Epub 2020 Feb 7. Head Neck. 2020. PMID: 32031301
TENERGY: multicenter phase II study of Atezolizumab monotherapy following definitive Chemoradiotherapy with 5-FU plus Cisplatin in patients with unresectable locally advanced esophageal squamous cell carcinoma.
Bando H, Kotani D, Tsushima T, Hara H, Kadowaki S, Kato K, Chin K, Yamaguchi K, Kageyama SI, Hojo H, Nakamura M, Tachibana H, Wakabayashi M, Fukutani M, Togashi Y, Fuse N, Nishikawa H, Kojima T. Bando H, et al. Among authors: nakamura m. BMC Cancer. 2020 Apr 20;20(1):336. doi: 10.1186/s12885-020-06716-5. BMC Cancer. 2020. PMID: 32312286 Free PMC article. Clinical Trial.
15,235 results
You have reached the last available page of results. Please see the User Guide for more information.